GDC-0941 and Cisplatin in Treating Patients With Androgen Receptor-Negative Triple Negative Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Cisplatin
Related studies linked through entity extraction aliases.
A Phase II Trial of Adjuvant Radiotherapy Combined With Chemotherapy for Patients With High-risk Endometrial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of MEHD7945A in Combination With Cisplatin and 5-Fluorouracil (5-FU) or Paclitaxel and Carboplatin in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN)
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Pilot Study Assessing Efficacy of a Cisplatin - Metronomic Cyclophosphamide Treatment in Patients With Metastatic Triple Negative Breast Cancer Resistant to Anthracyclines and Taxanes
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Pilot Study Assessing Efficacy of a Cisplatin - Métronomic Cyclophosphamide Treatment in Patients With Stade IV Triple Negative Breast Cancer Secondary Resistant to Anthracyclines and Taxanes
- Status
- TERMINATED
- Phase
- PHASE2
The Efficacy and Safety of Palonosetron in Preventing the Gastrointestinal Reactions Induced by 3-day Highly Emetogenic Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Nintedanib (BIBF 1120) in Mesothelioma
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
A Study to Assess Radiation Induced Mucositis in Patients of Head and Neck Cancer Administered Chemo-Radiation With or Without P276-00
- Status
- COMPLETED
- Phase
- PHASE2
Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Nab-Pac+Cis+Gem in Pts w Previously Untreated Metastatic PDA
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Sirolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients At High Risk for Cholangiocarcinoma Recurrence After Liver Transplant or Surgery
- Status
- COMPLETED
- Phase
- PHASE1
Therapeutic Strategy Guided by PET-TDM for Patients With Seminoma
- Status
- RECRUITING
- Phase
- PHASE2
Induction Chemotherapy With TP+5-FU or TP+Cetuximab Followed by Radioimmuptherapy for Locally Advanced or Not Resectable SCCHNN
- Status
- COMPLETED
- Phase
- PHASE2
AF CRT +/- Nimorazole in HNSCC
- Status
- UNKNOWN
- Phase
- PHASE3
A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Determination of Cetuximab Versus Cisplatin Early and Late Toxicity Events in HPV+ OPSCC
- Status
- UNKNOWN
- Phase
- PHASE3
Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase II Study of Six Hours Low Dose Gemcitabine Plus Cisplatin in the Treatment for Advanced Pleural Mesothelioma
- Status
- UNKNOWN
- Phase
- PHASE2
Study to Evaluate GSK3052230 in Combination With Paclitaxel and Carboplatin, or Docetaxel or as Single Agent in Subjects With Solid Malignancies and Deregulated Fibroblast Growth Factor (FGF) Pathway Signaling
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant Chemo for Non-metastatic Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2